Sutro Biopharma (STRO)
(Delayed Data from NSDQ)
$3.47 USD
-0.25 (-6.72%)
Updated Apr 24, 2024 04:00 PM ET
After-Market: $3.48 +0.01 (0.29%) 7:58 PM ET
3-Hold of 5 3
D Value C Growth B Momentum C VGM
Brokerage Reports
0 items in cart
Sutro Biopharma, Inc. [STRO]
Reports for Purchase
Showing records 1 - 20 ( 159 total )
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
STRO Sells a Three, Keeps Luvelta for the Finals
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
STRO''s Luvelta Getting Ready for the Season
Provider: Wedbush Securities Inc.
Analyst: NIERENGARTEN D
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Luvelta Forum Highlights its Future Potential and Attractive Positioning
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Luveltas Footprint Continues to be Undervalued; Reit. Buy and $16 PT
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Company: Sutro Biopharma, Inc.
Industry: Medical - Biomedical and Genetics
Luvelta Reports Encouraging Data for Endometrial Cancer During ESMO 23
Provider: H.C. Wainwright & Co., Inc.
Analyst: FEIN A